The School of Medicine and Health Sciences hosted the annual Universitas 21 Health Sciences Group conference.
Researchers from the Tec’s School of Medicine have obtained a patent after researching a plant extract for an eye disease called pterygium.
Reynaldo Lara, an infectious disease specialist at TecSalud, answers questions about whether it’s a good idea for people who’ve been vaccinated to take a different dose from another laboratory.
New variants of the virus that causes COVID-19 make it spread easier and faster. A TecSalud expert answers questions about these variants.
Dr. Guillermo Torre, researcher, clinician, and surgeon, has helped establish an innovative system at TecSalud, Tec de Monterrey’s health system.
Lisandra Vila Ellis, who holds a medical degree from the Tec de Monterrey School of Medicine, has won a United States research project grant after discovering a new lung cell.
TecSalud and NovocellBio signed a collaboration agreement to start the NK (natural killer) immune cell culture protocol.
TecSalud demonstrates research leadership by participating in the German CureVac COVID-19 vaccine clinical trial.
Health experts explain why wearing two face masks, or a single mask with a tight fit to the face, offers greater protection against COVID-19.
TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.